Download PDF
Int J Angiol 2015; 24(02): 113-120
DOI: 10.1055/s-0034-1376318
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Abdominal Aortic Diameter and the Risk for Asymptomatic Peripheral Arterial Disease in Patients with Type 2 Diabetes

Moatasem Salah Amer
1   Department of Geriatrics and Gerontology, Ain Shams University, Cairo, Egypt
,
Omar Hussien Omar
2   Department of Radiodiagnosis, Ain Shams University, Cairo, Egypt
,
Randa Abdel Wahab Reda
3   Department of Clinical Pathology, Ain Shams University, Cairo, Egypt
,
Tomader Taha Abdel Rahman
1   Department of Geriatrics and Gerontology, Ain Shams University, Cairo, Egypt
,
Doha Rasheedy
1   Department of Geriatrics and Gerontology, Ain Shams University, Cairo, Egypt
› Author Affiliations
Further Information

Publication History

Publication Date:
19 May 2014 (online)

    Permissions and Reprints

Abstract

Peripheral arterial disease (PAD) is common among older people because it often results from atherosclerosis, which becomes more common with age. The disease is particularly common among people who have diabetes. Little information is available on the relation between abdominal aortic diameter and PAD in elderly patients with diabetes. This article studies the relationships between abdominal aortic diameter, PAD, and the cardiovascular risk factors in asymptomatic elderly patients suffering from type 2 diabetes mellitus. A case–control study was conducted on 90 participants aged 60 years and older divided into 60 cases (30 males and 30 females) and 30 age-matched healthy controls (15 males and 15 females). The relationships between the size of the abdominal aorta and ankle–brachial index (ABI), plasma cholesterol, triglycerides (TG), and high-sensitivity C-reactive protein were examined. Approximately, 15% of patients with diabetes had asymptomatic PAD. The patients with diabetes with PAD were of older age (70.4 ± 3.6 vs. 63.4 ± 3.9 years; p = 0.000), had larger abdominal aortic diameter (22.4 ± 3.08 vs. 18.7 ± 2 mm; p = 0.000), and higher CRP levels (8.3 ± 1.1 vs. 5.8 ± 2.2 mg/L; p = 0.002), while other variables revealed no significant difference. Abdominal aortic diameter correlated well with ABI measured by Doppler method in diabetic patients (r =  − 0.471, p = 0.000). Older age and larger abdominal aorta are independent risk factors for asymptomatic PAD in the elderly with type 2 diabetes mellitus.

Keywords

peripheral arterial disease - abdominal aortic diameter - diabetes mellitus - ankle–brachial index - C-reactive protein

Note

All authors have read and approved the submission of the manuscript. The manuscript has not been published and is not under consideration of publication in whole or part except as an abstract.


 

  • References

  • 1 Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 2006; 47 (5) 921-929
    Google Scholar
  • 2 Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287 (19) 2570-2581
    CrossrefPubMedGoogle Scholar
  • 3 Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110 (6) 738-743
    CrossrefPubMedGoogle Scholar
  • 4 Gregg EW, Sorlie P, Paulose-Ram R , et al; 1999-2000 national health and nutrition examination survey. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 2004; 27 (7) 1591-1597
    CrossrefPubMedGoogle Scholar
  • 5 Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001; 24 (8) 1433-1437
    CrossrefPubMedGoogle Scholar
  • 6 American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26 (12) 3333-3341
    CrossrefPubMedGoogle Scholar
  • 7 Palazzuoli A, Gallotta M, Guerrieri G , et al. Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population. Vasc Health Risk Manag 2008; 4 (4) 877-883
    PubMedGoogle Scholar
  • 8 Ahlgren AR, Hansen F, Sonesson B, Länne T. Stiffness and diameter of the common carotid artery and abdominal aorta in women. Ultrasound Med Biol 1997; 23 (7) 983-988
    CrossrefPubMedGoogle Scholar
  • 9 Meijer WT, Grobbee DE, Hunink MG, Hofman A, Hoes AW. Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med 2000; 160 (19) 2934-2938
    CrossrefPubMedGoogle Scholar
  • 10 Allardice JT, Allwright GJ, Wafula JMC, Wyatt AP. High prevalence of abdominal aortic aneurysm in men with peripheral vascular disease: screening by ultrasonography. Br J Surg 1988; 75 (3) 240-242
    CrossrefPubMedGoogle Scholar
  • 11 Galland RB, Simmons MJ, Torrie EP. Prevalence of abdominal aortic aneurysm in patients with occlusive peripheral vascular disease. Br J Surg 1991; 78 (10) 1259-1260
    CrossrefPubMedGoogle Scholar
  • 12 Pedersen OM, Aslaksen A, Vik-Mo H. Ultrasound measurement of the luminal diameter of the abdominal aorta and iliac arteries in patients without vascular disease. J Vasc Surg 1993; 17 (3) 596-601
    CrossrefPubMedGoogle Scholar
  • 13 Mohler III ER. Peripheral arterial disease: identification and implications. Arch Intern Med 2003; 163 (19) 2306-2314
    CrossrefPubMedGoogle Scholar
  • 14 Weiss JS, Sumpio BE. Review of prevalence and outcome of vascular disease in patients with diabetes mellitus. Eur J Vasc Endovasc Surg 2006; 31 (2) 143-150
    CrossrefPubMedGoogle Scholar
  • 15 Elhadd T, Robb R, Jung R, Stonebridge P, Belch J. Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Pract Diabetes Int 1999; 16: 163-166
    CrossrefPubMedGoogle Scholar
  • 16 Hirsch AT, Criqui MH, Treat-Jacobson D , et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286 (11) 1317-1324
    CrossrefPubMedGoogle Scholar
  • 17 Golledge J, Karan M, Moran CS , et al. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J 2008; 29 (5) 665-672
    CrossrefPubMedGoogle Scholar
  • 18 Shantikumar S, Ajjan R, Porter KE, Scott DJ. Diabetes and the abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2010; 39 (2) 200-207
    CrossrefPubMedGoogle Scholar
  • 19 Le MT, Jamrozik K, Davis TM, Norman PE. Negative association between infra-renal aortic diameter and glycaemia: the Health in Men Study. Eur J Vasc Endovasc Surg 2007; 33 (5) 599-604
    CrossrefPubMedGoogle Scholar
  • 20 Allison MA, Kwan K, DiTomasso D, Wright CM, Criqui MH. The epidemiology of abdominal aortic diameter. J Vasc Surg 2008; 48 (1) 121-127
    CrossrefPubMedGoogle Scholar
  • 21 Tavintharan S, Ning Cheung, Tay W, Shankar A, Shyong Tai E, Wong TY ; Su Chi Lim. Prevalence and risk factors for peripheral artery disease in an Asian population with diabetes mellitus. Diab Vasc Dis Res 2009; 6 (2) 80-86
    CrossrefPubMedGoogle Scholar
  • 22 Allison MA, Criqui MH, McClelland RL , et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006; 48 (6) 1190-1197
    CrossrefPubMedGoogle Scholar
  • 23 Al-Delaimy WK, Merchant AT, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med 2004; 116 (4) 236-240
    CrossrefPubMedGoogle Scholar
  • 24 Rajkumar C, Bonapace S, Starr J, Radia M, Bulpitt CJ. Association between abdominal aortic diameter and peripheral vascular disease. J Hum Hypertens 1997; 11 (9) 589-591
    CrossrefPubMedGoogle Scholar
  • 25 Shankar A, Li J, Nieto FJ, Klein BE, Klein R. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. Am Heart J 2007; 154 (3) 495-501
    CrossrefPubMedGoogle Scholar
  • 26 Doi Y, Kiyohara Y, Kubo M , et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study. Diabetes Care 2005; 28 (10) 2497-2500
    CrossrefPubMedGoogle Scholar
  • 27 Mugabo Y, Li L, Renier G. The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings. Curr Diabetes Rev 2010; 6 (1) 27-34
    CrossrefPubMedGoogle Scholar
  • 28 Vu JD, Vu JB, Pio JR , et al. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease. Am J Cardiol 2005; 96 (5) 655-658
    CrossrefPubMedGoogle Scholar